Proactive Investors - Run By Investors For Investors

G Medical Innovations receives regulatory approval for China production facility

The company specialises in e-health technologies and solutions using a suite of devices and software.
G Medical Innovations receives regulatory approval for China production facility
G Medical last traded at 34 cents per share

G Medical Innovations Holdings Ltd (ASX:GMV) has been granted CE, FDA and CFDA regulatory approvals for its medical device production facility in Guangzhou, China.

The company completed a multi-stage independent audit process and expects to receive final certification documentation from the regulatory bodies within 3 weeks.


G Medical chief executive officer Yacov Geva said: “We are very pleased to have achieved CE, FDA and CFDA approval, which exemplifies the high-quality of our production facility and our strong in-country relationships.

“The company has been committed to achieving this major milestone in record timeframes and we now look forward to being able to meet the demand from our global partnerships and rapidly execute our commercial plans.”

READ: G Medical Innovations moving towards US public offering and NASDAQ listing

The mobile and e-health company has numerous global agreements in place and the regulatory approvals enable production and distribution to territories requiring CE, FDA and CFDA certification to begin.

G Medical has a strong pipeline of customer demand and the increased production capacity will position the company to fulfil its expansion into the growing e-health market.

Preparations for the listing of Chinese subsidiary Guangzhou Yimei Innovative Medical Science and Technology Co Ltd on the Hong Kong Stock Exchange are ongoing.

The company has requested its securities remain in trading halt pending an announcement on a capital raising and a material acquisition.

View full GMV profile View Profile

G Medical Innovations Holdings Ltd Timeline

Related Articles

An armour plate based on XTclave technology
April 28 2019
The upper limit of the defence supplier’s guidance this half-year is $21.6 million.
Restaurant diners
June 07 2019
The company's website and phone app aims to help restaurants fill spare capacity by offering discounts potential diners during quieter periods
Hundred dollar bills float through air, signalling affluence of Animoca's partnerships
April 22 2019
Animoca Brands is a rapidly growing games company always on the move and seeking new growth opportunities.
Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use